Study of the ONS "Nutrinidrink With Dietary Fiber" Use Effect on Some Health Indicators in Children With Cerebral Palsy
NCT ID: NCT05581732
Last Updated: 2023-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
56 participants
OBSERVATIONAL
2021-06-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy
NCT05648422
Whole Body Metabolism in Children With Cerebral Palsy With Low Skeletal Muscle Mass
NCT06486597
Effect of a Nutritional Support System for Improving Gross Motor Function in Cerebral Palsy
NCT03933709
Diet and Activity in Cerebral Palsy
NCT02175108
Cerebral Palsy & Predictors of Physical Activity
NCT04614207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study
32 patients in the study group received supplemental nutritional support with ONS "Nutrinidrink with Dietary Fiber" in a pre-calculated amount daily throughout the study for 14-16 weeks. During the hospital stay, additional nutritional support was added to the patient's standard hospital diet (ATC table). On an outpatient basis, the patient received the required amount of ONS at his disposal and add it as a supplement to his/her usual and habitual diet between main meals.
Nutrinidrink with Dietary Fiber
Nutrinidrink with Dietary Fiber is a specialized nutrition for children during illness and recovery period, as well as with increased protein and energy needs: mental and / or physical stress, chronic diseases, growth and / or weight deficiency
Control
24 patients in the control group adhered to the standard hospital diet (ATC table), and at discharge - the usual habitual diet
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutrinidrink with Dietary Fiber
Nutrinidrink with Dietary Fiber is a specialized nutrition for children during illness and recovery period, as well as with increased protein and energy needs: mental and / or physical stress, chronic diseases, growth and / or weight deficiency
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Class of cerebral palsy GMFCS 2-3;
* Z-score BMI ≤ -1;
* The patient's ability to safely swallow liquid food;
* Availability of informed consent signed by the patient's legal representative for inclusion in the study and processing of personal data.
Exclusion Criteria
* Galactosemia;
* Allergy to cow's milk proteins and other food intolerances;
* Participation in another clinical study currently or in the past 30 days;
* Any other medical or non-medical reason that, in the physician's opinion, may prevent the patient from participating in the study.
* Deterioration of the patient's condition requiring his transfer to enteral or parenteral nutrition;
* Transfer of a patient to another hospital;
* Complications that could be caused by the investigational product (diarrhea, nausea, vomiting, allergies, etc.);
* Withdrawal for a safety reason
* Refusal of the patient (his legal representative) from further participation in the study and withdrawal of informed consent to participate in the study and the processing of personal data. At the same time, the exclusion of a patient from the study should not affect the nature of his therapy
4 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danone Nutricia
INDUSTRY
Enrollme.ru, LLC
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikhail A Getman, Dr
Role: STUDY_DIRECTOR
Enrollme.ru
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for nutrition and biotechnology
Moscow, , Russia
Scientific and Clinical Center for Children's Psychoneurology
Moscow, , Russia
Child's Clinical Hospital by Ivanova
Samara, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOCP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.